FAMBB

SPONSORED FEATUREThinking differently: innovatingto improve global public healthTXXXXXXXXXXBeyond the Millennium Development GoalsThe global health community has made great strides in advancingglobal healthcare over the past decade. Improved technologieshave allowed us to forward medical breakthroughs, while novelorganisations and policies have put these tools into the hands of morepeople in need than ever before.The UN Millennium Development Goals (MDGs) have played a keyrole in the progress we have made. With targeted, quantifiable objectives,the MDGs have served as a powerful force, bringing together public healthstakeholders from all sectors unified by a common cause.But the world is changing around us every day. The global healthcommunity must work to accommodate the dynamic essence of publichealth challenges. The 2015 deadline for achieving the MDGs is fastapproaching, yet the world is on track to meet only a portion of what wehad set out to accomplish. This collective shortcoming signals the needto think differently. Going forward, we must find new models of thoughtand action that extend beyond convention to create novel health solutions,breaking down the barriers to scientific discovery and access that precludehealth for all.Janssen Global Public Health: working collaboratively towards changeAt Janssen Global Public Health (Janssen GPH), we are approachingseemingly intractable health challenges in new and creative ways. Everythingwe do is based on an ‘out-of-the-box’ approach – from research anddevelopment to access and policymaking – with the understanding that weneed to create actionable solutions to improve health worldwide.Collaboration is a powerful driver of change. Our company has a longlegacy of working with partners to improve health. We are fully committedto innovating and getting our tools to health systems and patients throughdiverse – and sometimes unexpected – channels. We are working in directpartnership with domestic and global researchers, implementers, andpolicymakers across sectors to deliver on our promises and to maximise ourimpact.●●Expanding access to all. Beyond the laboratory, we are reimagining howwe can sustainably deliver our medical tools to those in need. We havedevised innovative pricing schemes, results-based financing mechanisms,and commercial access models to enhance access to our HIV and TBmedicines for patients in resource-limited and emerging markets.●●Strengthening health systems. We are also creating sustainable, longtermsolutions based on country ownership and accountability for healthservices and outcomes. Working with local governments in public-privatepartnerships will not only allow us to get our health innovations topatients, it will also help build local capacity. Our partnerships strengthenlocal health systems through medical education sessions on appropriateuse of our medicines; disease management programmes that integratecomprehensive health solutions into local systems; and a pediatric HIVtreatment initiative that builds awareness and action around the importantissue.Our call to actionAt Janssen Global Public Health, we are a new model of collaboration andinnovation. We want to improve health for people everywhere by pushingthe boundaries of medicine. Our approach is constantly evolving to meet thechanging needs of health systems and the patients we serve.We believe there are countless possibilities ahead for us to make ameaningful difference in public health and a multi-sector, collaborativeapproach is the best way forward. We must be ambitious, creative andproactive – both for the long-term sustainability of our efforts, and moreimportantly for the people we are working to help. We are thinking – andacting – differently to advance health for all. Together, we can create ahealthier world.The content of this piece is written and supported by Janssen Pharmaceutica N.V.●●Research & development. Our dedicated teams of scientists and researchersare driven to create and deliver tailored therapeutic solutions tomeet local needs. Through collaboration, we are working to alleviate sufferingaffiliated with diseases that disproportionately affect people livingin resource-limited settings, including multi-drug resistant tuberculosis,HIV, and neglected tropical diseases.